Europe Says Johnson & Johnson Paid to Delay Generic Fentanyl
Thursday, January 31, 2013 - 22:40
in Health & Medicine
Johnson & Johnson and Novartis were accused of colluding to delay the availability of a less expensive version of a pain medication for cancer patients.